Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Preparation and Drug-Loading Properties of Amphoteric Cassava Starch Nanoparticles

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      MDPI AG
    • الموضوع:
      2022
    • Collection:
      Directory of Open Access Journals: DOAJ Articles
    • نبذة مختصرة :
      Based on the characteristics of charge reversal around the isoelectric point (pI) of amphoteric starch-containing anionic and cationic groups, amphoteric cassava starch nanoparticles (CA-CANPs) are prepared by a W/O microemulsion crosslinking method using (3-chloro-2-hydroxypropyl) trimethyl ammonium chloride as a cationic reagent and POCl 3 as an anionic reagent, and the effects of preparation conditions on the particle size of the CA-CANPs are studied in detail in the present study. CA-CANPs with a smooth surface and an average diameter of 252 nm are successfully prepared at the following optimised conditions: a crosslinking agent amount of 15 wt %, an aqueous starch concentration of 6.0 wt %, an oil–water ratio of 10:1, a total surfactant amount of 0.20 g·mL −1 , and a CHPTAC amount of 4.05 wt %. The pH-responsive value of the CA-CANPs can be regulated by adjusting the nitrogen–phosphorus molar ratio in the CA-CANPs. By using CA-CANPs with a pI of 6.89 as drug carriers and the paclitaxel (PTX) as a model drug, the maximum loading rate of 36.14 mg·g −1 is achieved, and the loading process is consistent with the Langmuir isotherm adsorption, with the calculated thermodynamic parameters of Δ H ° = −37.91 kJ·mol −1 , Δ S ° = −10.96 J·mol −1 ·K −1 and Δ G ° < 0. By testing the release rate in vitro, it is noted that the release rates of PTX in a neutral environment (37.6% after 96 h) and a slightly acidic environment (58.65% after 96 h) are quite different, suggesting that the CA-CANPs have the possibility of being a targeted controlled-release carrier with pH responsiveness for antitumor drugs.
    • ISSN:
      2079-4991
    • Relation:
      https://www.mdpi.com/2079-4991/12/4/598; https://doaj.org/toc/2079-4991; https://doaj.org/article/b04ca9217ec44e3daa107181f33f24e8
    • الرقم المعرف:
      10.3390/nano12040598
    • الرقم المعرف:
      edsbas.28F4DB87